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Abstract
Background: H6N1 low pathogenic avian influenza virus (LPAIV) are frequently isolated in Taiwan and lead to
significant economic losses, either directly or indirectly through association with other infectious diseases. This
study investigates immune responses to three different vaccines following a H6N1 challenge in different local
breeds.
Methods: Experimental animals were sampled from six local chicken breeds maintained at the National Chung-
Hsing University, namely Hsin-Yi, Ju-Chi, Hua-Tung (Taiwan), Quemoy (Quemoy Island), Shek-Ki (China), Nagoya
(Japan) and a specific pathogen free (SPF) White Leghorn line. A total number of 338 chickens have been
distributed between a control and a challenge group, H6N1 challenge was performed at 7 weeks of age;
vaccination against Newcastle Disease (ND), Infectious Bursal Disease (IBD) and Infectious Bronchitis (IB) was
performed at 11 weeks. The anti-H6N1 LPAIV antibody titers were measured by ELISA at days 0, 7, 14 and 21 after
challenge, and the anti-ND, anti-IBD and anti-IB antibody titers were measured by inhibition of hemagglutination
test and ELISA at days 0, 14, 28 after vaccination.
Results: There was no effect of the H6N1 LPAIV challenge at 7 weeks of age on the subsequent responses to ND
and IBD vaccine at 11 weeks of age, but, surprisingly, the H6N1 LPAIV challenge significantly affected antibody
levels to IB vaccine in some breeds, since IB0 and IB14 antibody titers were lower in the challenge groups.
However, there was no significant difference in IB28 antibody titers among the experimental groups.
Conclusions: Local breeds have different immune response to H6N1 LPAIV challenge and subsequent vaccines.
Differences dealt mainly with kinetics of response and with peak values. Quemoy exhibited higher antibody levels
to H6N1, ND and IBD. The negative effect of the H6N1 LPAIV challenge on IB vaccine response may be related to
the fact that both viruses target the lung tissues, and the type of local immune response induced by LPAIV
challenge may not be favourable for birds to make optimum IB-specific antibody response.
* Correspondence: fattelos@gmail.com
1Department of Animal Science, National Chung-Hsing University, Taiwan, R.
O.C
Full list of author information is available at the end of the article
Chang et al. BMC Proceedings 2011, 5(Suppl 4):S33
http://www.biomedcentral.com/1753-6561/5/S4/S33
© 2011 Chang et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Background
Since 1982, National Chung-Hsing University is maintain-
ing six local chicken breeds: Hsin-Yi, Ju-Chi and Hua-Tung
were collected from small villages in Taiwan, Quemoy was
collected from Quemoy Island near China, Shek-Ki was
from China, and Nagoya was from Japan [1]. In previous
studies, Quemoy had significantly higher antibody titers
against Newcastle Disease (ND) after vaccination than
other local breeds, Shek-Ki, Hua-Tung and Ju-Chi had
lower anti-ND antibody titers [2]. Thus, immune response
was shown to differ within this set of local chicken breeds.
H6N1 Low pathogenic Avian Influenza Virus (LPAIV)
is frequently isolated in Taiwan and lead to significant
economic losses, either directly or indirectly through
association with other infectious diseases [3]. This study
investigated immune responses to ND, Infectious Bron-
chitis (IB) and Infectious Bursal Disease (IBD) vaccines
following a H6N1 LPAIV challenge on six local chicken
breeds and SPF chicken.
Methods
Experimental chickens
In this study we used the six local breeds and added an
SPF White Leghorn as a control genotype.
A total of 314 chicks were hatched from 23 sires and 91
dams with full pedigree in six local breeds. Twenty-five SPF
chicks were purchased from Animal Health Research Institute
(Council of Agriculture, Executive Yuan R.O.C.). Day-old
chicks were wing-banded and raised in floor pens until 5
weeks of age, and they were transferred to experimental cages
after 6 weeks of age. Sire families were distributed between
the control and the challenge group. Individual body weights
were recorded weekly from hatch to 16 weeks of age.
Vaccination program and challenge
Day-old chicks were all vaccinated against Marek’s disease
and ND. At two weeks of age, chicks were vaccinated
against ND, IB, IBD, Fowl Pox and Avian Reovirus infec-
tion. At four weeks of age, chickens were vaccinated against
ND, IB, IBD and Infectious Laryngotracheitis. The H6N1
LPAIV (A/chicken/Taiwan/0825/2006) challenge was per-
formed at 7 weeks of age, birds from the challenge group
received a drop with 107 EID50 of viruses into eye and nose.
Blood samples were collected at days 0, 7, 14 and 21 post-
challenge. Chickens health condition and mortality were
recorded and monitored. At 11 weeks of age, all chickens,
from both challenge and control groups, were vaccinated
again against ND, IB and IBD, blood samples were collected
at days 0, 14 and 28 post-inoculation. Sera from blood sam-
ples were collected and stored in -20 °C refrigerator.
Immune response measurement
The antibody responses to H6N1 LPAIV, IBD and IB were
measured by enzyme-linked immunosorbent assay (ELISA)
with commercial test kit (IDEXX Laboratories, Inc., West-
brook, ME), the antibody titer calculation was performed
according to IDEXX’s formula. The antibody responses to
ND were measured by hemagglutination inhibition test
(HIT), the antibody titer was expressed as the log2 of the
reciprocal of the highest dilution. Each measure was
defined by the virus name (AI, ND, IBD or IB) and the day
of sampling after inoculation (either days 0, 7, 14, 21 or
28). In addition, response to IB vaccine was calculated by
the difference in antibody titers between stages, i.e. day 0
to day 14, day 14 to day 28 and day 0 to day 28.
Statistical analysis
Antibody titers and differences between successive titers
were analysed with the following statistical model,
Y s eijkl i j k ij ijkl= + + + + +m t a ta( )
where Yijkl is the antibody titer of the lth animal of the
ith breed, the kth sex after the jth challenge treatment,
i=1, 2,…,7, j=1,2, k=1,2, l=1,2,…,338, μ is the mean, τi is
the fixed effect of the ith breed, Στi=0, aj is the fixed
effect of the jth challenge treatment, Σaj=0, (τa)ij is the
fixed interaction effect between the ith breed and the
jth challenge treatment , ΣΣ(τa)ij=0, and eijkl is the resi-
dual random error, e Nijkl e∩ ( , )0
2s .
All statistical analyses were conducted by using SAS
software (SAS Institute).
Results
H6N1 LPAIV challenge
There was no mortality for Quemoy, Nagoya and SPF chick-
ens (Table 1). Ju-Chi, Hua-Tung and Shek-Ki exhibited a
low mortality (one bird each), and Hsin-Yi had the highest
mortality: 7 birds (22.6%, see Table 1). Most of mortality
occurred between day 7 and 14 post-challenge. The analysis
of variance showed a significant effect of breed on all anti-
body titers, no effect of sex, and a significant effect of the
challenge with a significant breed with challenge interaction
on antibody titers from day 7 (Fig 1). This interaction was
due to differential response between breeds: Quemoy had
the highest antibody titer on day 7 and 14 post-challenge,
Hua-Tung showed the highest antibody titer on day 21
post-challenge, Nagoya and SPF showed lower antibody titer
on day 14 and 21 post-challenge. Quemoy was the only
breed to exhibit a significant antibody titer at day 7 post-
challenge. The anti-AI antibody titers were significantly
higher for all breeds at days 14 and 21 post-challenge.
ND vaccine response
There was no effect of the H6N1 LPAIV challenge on
anti-ND antibody titers at day 14 and 28 post-inocula-
tion (Fig 2). Nagoya was the only one to show a differ-
ence of anti-ND antibody titer between the control and
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challenge groups at day 0, with a lower value in the
challenge group. The breed effect was significant at all
stages and the sex effect was not (data not shown). The
Quemoy and SPF had high antibody levels from ND0 to
ND28. Ju-Chi showed the lowest response to ND vacci-
nation at day 28 post-inoculation.
IBD vaccine response
There was a significant effect of breed and no effect of
the H6N1 LPAIV challenge on anti-IBD antibody titers
at all stages. Interaction between breed and treatment
tended to be significant at day 28 (P < 0.05) where the
Quemoy was the only one to show significantly lower
antibody titers in the challenge group (Fig 3). There was
a significant sex effect on responses at days 14 and 28
post-inoculation, and the antibody titers were higher in
females than in males (data not shown). Nagoya and
SPF showed no response to vaccination, but antibody
titers of Nagoya were rather high at day 0. Quemoy and
Hsin-Yi showed the highest antibody levels, particularly
at day 28 post-inoculation. Ju-Chi, Hua-Tung and SPF
showed the lowest antibody titers at all stages.
IB vaccine response
In contrast with the results observed for ND and IBD,
the kinetics of antibody titers of IB was modified by
the H6N1 LPAIV challenge (Fig 4). Interactions
between breed and treatment, as well as between breed
and sex, were significant for IB0. Antibody titers at day
0 were lower in the challenge group than in the con-
trol group for Ju-Chi and SPF, but did not differ
between groups for the other breeds (Fig 5). The
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Figure 1 Antibody titers against H6N1 LPAIV on 0, 7, 14 and 28 days post-challenge. a,b within days post-challenge with no common
superscript differ significantly (P < 0.05) in Quemoy. *means all breeds have significantly different between control and challenge group.
Table 1 Sample size and mortality per breed in H6N1 challenge experiment
Hsin-Yi Ju-Chi Hua-Tung Quemoy Shek-Ki Nagoya SPF
Control group 31 25 23 42 9 15 12
Challenge group 31 27 28 49 12 22 12
Total size 62 52 51 91 21 37 24
Mortality* 7 1 1 0 1 0 0
Mortality rate (%) 22.6 3.7 3.6 0 8.3 0 0
* Mortality was calculated within challenge group.
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Figure 2 Antibody titers against ND on 0, 14 and 28 days post-inoculation. * Nagoya showed a difference of anti-ND antibody titer
between the control and challenge groups at day 0, with a lower value in the challenge group.
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Figure 3 Antibody titers against IBD on 0, 14 and 28 days post-inoculation. * Quemoy showed significantly lower antibody titer in the
challenge group.
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Figure 4 Antibody titers against IB on 0, 14 and 28 days post-inoculation. a,b within days post-inoculation with no common superscript
differ significantly (P < 0.05).
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Figure 5 Antibody titers against IB on 0, 14 and 28 days post-inoculation. * Antibody titers at day 0 were lower in the challenge group
than in the control group for Ju-Chi and SPF. The effects of breed and H6N1 challenge, without any interaction, were still observed at day 14
post-inoculation. Higher antibody levels were found in the control group for all breeds. Nagoya was the only one to exhibit a stronger response
to IB vaccine in the H6N1 control group at day 14.
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effects of breed and H6N1 challenge, without any
interaction, were still observed at day 14 post-inocula-
tion. Higher antibody levels were found in the control
group for all breeds. Nagoya was the only one to exhi-
bit a stronger response to IB vaccine in the H6N1 con-
trol group at day 14, as measured by the difference
between titers at day 14 and day 0 (Table 2). The
interaction between breed and sex was still significant
at day 14 but was not observed at day 28. Breed and
treatment effects were significant at day 28; antibody
titers became higher in the challenge groups than in
the control groups, whatever the breed. The increase
in antibody titers between day 14 and day 28 was
always higher in the challenge groups as compared to
the control groups, this difference was highly signifi-
cant in Ju-Chi and Nagoya (Table 2) and tended to be
significant (P < 0.05) in all other breeds except Shek-
Ki which never showed any difference in anti-IB titers
between the challenged and the control groups.
Breed comparison showed that Quemoy had the high-
est antibody titers for IB0. Quemoy, Hsin-Yi and Nagoya
had the highest values for IB14. These three breeds had
still high values for IB28, but Shek-Ki had also high
values for IB28, although it exhibited low values for IB0
and IB14. Thus, this breed was characterized by a late
and strong response to IB vaccine, without any signifi-
cant effect of the previous H6N1 challenge.
Discussion and conclusions
H6N1 LPAIV challenge effect
Mortality data and the increased antibody titers of chal-
lenge group at day 14 post-challenge showed that the
challenge test had been effective. Estimation of breed
effects may be affected by limited sample size, particu-
larly for Shek-Ki, SPF and Nagoya. However, Quemoy
had the largest sample size, and can be identified as the
most resistant breed since it did not show any mortality
after the challenge, and exhibited the most rapid
immune response at day 7 post-challenge. At the oppo-
site, Hsin-Yi can be identified as the most susceptible
breed, with a rather high mortality (7 birds out of 26) in
spite of the use of a low pathogenic virus.
Breeds effect, vaccine efficacy and duration of immunity
Antibodies were detected for ND, IB and IBD at day 0
post-inoculation because all chickens had been vacci-
nated for ND, IB and IBD at earlier ages. Thus, the
immune response following the inoculation at 11 weeks
of age may be considered as a secondary immune
response. Antibody titers at day 14 post-inoculation
were significantly higher than at day 0, showing vaccine
efficiency, except in the case of Nagoya and SPF for IBD
vaccine where no change in antibody levels was
observed.
Breed significantly affected immune response. Quemoy
had high and rapid responses to the three vaccines and
to H6N1 LPAVI challenge test, in contrast to Ju-Chi
which had low immune response to vaccines and chal-
lenge test. Breed’s effect on the antibody titers at day 0
revealed differences in the duration of immunity to pre-
vious vaccines. Quemoy appeared to have a better
immunity than other breeds, Shek-Ki had a slow
response to ND and IB, and Ju-Chi presented lowest
response to IBD. The better immune response of Que-
moy is consistent with previous results [2].
H6N1 LPAIV challenge effect on IB immune response
H6N1 LPAIV challenge had a negative effect on anti-
body levels to IB even before the vaccination at 11
weeks of age. Immune response to IB vaccine took place
in H6N1 challenge groups with some delay (after 14
days). The negative relationship of H6N1 LPAIV chal-
lenge and IB vaccine response could be related to the
fact that both viruses target the lung tissues. Recently,
Haghighat-Jahromi et al. [4] showed that coinfection of
H9N2 AI virus with IB live virus enhanced the virulence
of H9N2 and increased the rate of mortality. In addition,
Karimi-Madab et al. [5] showed that IB live vaccine
Table 2 Effects of H6N1 challenge on antibody titers in
different periods across breeds
Breed Period* Control Challenge
Hsin-Yi IB14-IB0 6253 ± 499 5106 ± 499
IB28-IB0 8119 ± 609 8769 ± 609
IB28-IB14 1852 ± 726 3722 ± 738
Ju-Chi IB14-IB0 4598 ± 553 3374 ± 541
IB28-IB0 3474 ± 682b 5720 ± 608a
IB28-IB14 -946 ± 564b 2408 ± 564a
Hua-Tung IB14-IB0 4818 ± 877 3175 ± 784
IB28-IB0 7149 ± 604 7461 ± 540
IB28-IB14 2331 ± 766 4303 ± 699
Quemoy IB14-IB0 3633 ± 508 3424 ± 469
IB28-IB0 5261 ± 447 6362 ± 413
IB28-IB14 1663 ± 502 2935 ± 463
Shek-Ki IB14-IB0 2050 ± 687 1235 ± 615
IB28-IB0 9464 ± 623 9809 ± 623
IB28-IB14 7148 ± 938 8516 ± 884
Nagoya IB14-IB0 6117 ± 548a 3165 ± 437b
IB28-IB0 7038 ± 748 8718 ± 642
IB28-IB14 580 ± 844b 5433 ± 695a
SPF IB14-IB0 3205 ± 679 3063 ± 679
IB28-IB0 3186 ± 962b 6118 ± 962a
IB28-IB14 -19 ± 1107 3055 ± 1107
*IB14-IB0 represents the difference between IB14 and IB0, IB28-IB0 the
difference between IB28 and IB0 and IB28-IB14 the difference between IB28
subtract IB14.
a,b Means ± SE within a breed for a given stage with no common superscript
differ significantly (P < 0.05).
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could be an important risk factor resulting in enhanced
virulence of H9N2 LPAIV in field conditions. Although
these studies were focusing on broilers and H9N2
LPAIV, the present study shows also an interaction
between IB and H6N1 LPAIV infection in some local
chicken breeds. One could speculate that the type of
local immune response induced by H6N1 LPAIV infec-
tion was not favourable for birds to make optimum IB-
specific antibody response.
In conclusion, local breeds have different immune
response to H6N1 LPAIV challenge and subsequent vac-
cines. The H6N1 LPAIV challenge influenced the
response to subsequent vaccination against IB, but had
no effect on ND and IBD subsequent vaccines.
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